biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by SayitLykitizon Apr 15, 2011 12:13pm

228 Views

Post# 18437321

Missing the some "wow"...

Would have preferred a headline that indeed states "BiOasis research results validated by..." which is pretty unequivocal. Somehow the current chosen headline "Significant independent results..." intimates a less emphatic result. If you give it a good once/twice read-over though, all you need is there.
I have high hopes for BiOasis. So few shares... tightly held. Would love to see volume if only to indicate people know this thing is on the map.
Never did find the "poster" they presented... on their website. Did anyone?

Bullboard Posts

Unique Battery Metals opportunity in Quebec